CSI Market
Sign In | Register

Nurix Therapeutics Inc (NRIX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NRIX Annual Balance Sheets →
Tracking balance sheet results across Nurix Therapeutics Inc to May 31 2025 helps illustrate how May 31 2026's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(May 31 2026)
(Feb 28 2026) (Nov 30 2025) (Aug 31 2025) (May 31 2025)
Assets
Cash & cash equivalent67.69
Marketable Securities, Current SH0.16
Cash & Short-term Investments67.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current12.95
Total Current Assets456.48
Equipment/Property/Plant Net61.35
Other Assets, Noncurrent393.40
Debt Securities Available For Sale Excluding Accrued Interest Current469.54
Restricted Cash Noncurrent0.97
Total Assets535.54
Liabilities
Accounts Payable, Current AC12.21
Accrued Liabilities, Current13.45
Other Liabilities, Current46.12
Taxes Payable0.25
Total Current Liabilities72.02
Total Long-term Debt0.00
Other liabilities, Noncurrent60.89
Contract With Customer Liability Current18.75
Contract With Customer Liability Noncurrent7.59
Total Liabilities132.91
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock1,582.60
Retained Earnings / Accumulated Deficit-1,179.94
Accumulated Other Comprehensive Income-0.15
Other Equity-0.15
Common Stockholder's Equity402.63
Total Stockholder's Equity402.63
Liabilities & Stockholder's Equity535.54
4 historic quarters locked

Sign in to unlock the full Nurix Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Nurix Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001549595-26-000040

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.